The Haining Hairui Industrial Fund, initiated by Ankerui Electric Co., Ltd. in 2017 and established with 33 enterprises and individuals including Shandong Shengyang Power Supply Co., Ltd. and Changzhou Tenglong Automotive Parts Co., Ltd., invested in Shanghai Bide Pharmaceutical Technology Co., Ltd., which was listed on the Shanghai Stock Exchange Science and Technology Innovation Board on October 11, 2022, with stock code: 688073. Hai Rui Investment has invested twice in the excellent representative enterprise of molecular block field, Bide Pharmaceutical, in 2020 and 2021. Bide Pharmaceutical is the eighth listed enterprise of Hai Rui Investment. We warmly congratulate Bide Pharmaceutical and all shareholders.
Founded in 2007, BYD Pharmaceutical is a unique "little giant" enterprise that focuses on the front-end of the new drug research and development industry chain, with the fundamental values of serving people's life and health. Relying on core businesses such as research and development, design, production, and sales of drug molecular blocks, BYD Pharmaceutical can provide new drug research and development institutions with innovative structures and diverse functions of drug molecular blocks and scientific reagents. The company's main products are pharmaceutical molecular blocks and scientific reagents. After more than ten years of development, BYD Pharmaceutical has become one of the domestic molecular blocks below kilogram level.
Ankrui accounts for 19.72% of the investment in Hai Rui Industrial Fund and is a major investor. As of now, Hai Rui Investment manages over 20 funds with a total management scale of nearly 4 billion yuan. Since its establishment, Hai Rui Investment has invested in more than 60 high-quality enterprises. Among them, 8 enterprises have completed IPO listing, 1 enterprise has exited through mergers and acquisitions of listed companies, and multiple enterprises are waiting in line for review on exchanges.

Ankerui Electric Co., Ltd
October 12, 2022